BAYRY Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 15:59):

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments...

Stats
Today's Volume	2.12M
Average Volume	2.12M
Market Cap	30.34B
EPS	$0 ( 2024-05-09 )
Next earnings date	( $0.250 ) 2024-08-13
Last Dividend	$0.632 ( 2023-05-02 )
Next Dividend	$0 ( N/A )
P/E	-8.98
ATR14	$0.00500 (0.06%)

Volume Correlation

Long: -0.12 (neutral)

Short: 0.53 (weak)

Signal:(68.562) Neutral

Bayer Aktiengesellschaft Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Bayer Aktiengesellschaft Correlation - Currency/Commodity

0.53
( weak )

0.45
( neutral )

0.00
( neutral )

0.01
( neutral )

0.63
( weak )

Bayer Aktiengesellschaft Financials

Annual	2023
Revenue:	$47.64B
Gross Profit:	$27.89B (58.54 %)
EPS:	$-2.99

FY	2023
Revenue:	$47.64B
Gross Profit:	$27.89B (58.54 %)
EPS:	$-2.99

FY	2022
Revenue:	$50.74B
Gross Profit:	$30.87B (60.84 %)
EPS:	$4.22

Financial Reports:

No articles found.

Bayer Aktiengesellschaft Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0.632 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Bayer Aktiengesellschaft Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 2.93 - low (50.00%) | Divividend Growth Potential Score: 1.552 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.320	2001-04-25
Last Dividend	$0.632	2023-05-02
Next Dividend	$0	N/A
Payout Date	2023-05-15
Next Payout Date	N/A
# dividends	24	--
Total Paid Out	$12.19	--
Avg. Dividend % Per Year	0.00%	--
Score	1.41	--
Div. Sustainability Score	2.93
Div.Growth Potential Score	1.552
Div. Directional Score	2.24	--

Next Divdend (Est)
(2025-03-31)

$0.640 Estimate 3.12 %

Dividend Stability

0.25 Very Poor

Dividend Score

1.41

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
RWCB	Ex Dividend Knight	2023-07-28	Quarterly	0.00%
DIMC	Ex Dividend Knight	2023-09-28	Quarterly	0.00%
LDSCY	Ex Dividend Junior	2023-08-24	Quarterly	0.00%
ASXFY	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
SWRBY	Ex Dividend Knight	2023-09-12	Semi-Annually	0.00%
FBTT	Ex Dividend Knight	2023-09-21	Quarterly	0.00%
NACB	Ex Dividend Junior	2023-08-15	Quarterly	0.00%
BXBLY	Ex Dividend Knight	2023-09-13	Semi-Annually	0.00%
UEPCO	Ex Dividend Knight	2023-07-20	Quarterly	0.00%
HCBN	Ex Dividend Knight	2023-10-03	Quarterly	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0663	1.500	-1.327	-1.990	[0 - 0.5]
returnOnAssetsTTM	-0.0260	1.200	-0.867	-1.041	[0 - 0.3]
returnOnEquityTTM	-0.0898	1.500	-2.11	-3.16	[0.1 - 1]
payoutRatioTTM	-0.763	-1.000	-7.63	7.63	[0 - 1]
currentRatioTTM	1.311	0.800	8.44	6.75	[1 - 3]
quickRatioTTM	0.872	0.800	9.58	7.66	[0.8 - 2.5]
cashRatioTTM	0.154	1.500	-0.254	-0.381	[0.2 - 2]
debtRatioTTM	0.386	-1.500	3.57	-5.35	[0 - 0.6]
interestCoverageTTM	0.617	1.000	-0.883	-0.883	[3 - 30]
operatingCashFlowPerShareTTM	6.25	2.00	7.92	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.47	2.00	8.27	10.00	[0 - 20]
debtEquityRatioTTM	1.299	-1.500	4.80	-7.20	[0 - 2.5]
grossProfitMarginTTM	0.586	1.000	3.57	3.57	[0.2 - 0.8]
operatingProfitMarginTTM	0.0373	1.000	-1.255	-1.255	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.133	1.000	-0.374	-0.374	[0.2 - 2]
assetTurnoverTTM	0.392	0.800	-0.719	-0.575	[0.5 - 2]
Total Score				2.93

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-2.24	1.000	-0.327	0	[1 - 100]
returnOnEquityTTM	-0.0898	2.50	-1.356	-3.16	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.47	2.00	8.84	10.00	[0 - 30]
dividendYielPercentageTTM	0.454	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	6.25	2.00	7.92	10.00	[0 - 30]
payoutRatioTTM	-0.763	1.500	-7.63	7.63	[0 - 1]
pegRatioTTM	-0.923	1.500	-9.49	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.131	1.000	9.24	0	[0.1 - 0.5]
Total Score				1.552

Bayer Aktiengesellschaft Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.